Closing Bell: Cardiol Therapeutics Inc down on Thursday (CRDL)

Today, Cardiol Therapeutics Inc shares closed at $2.71 after opening the day at $2.90. It traded at a low of $2.71 to a high of $2.90.

Shares dipped -6.55 percent from the previous day's close of $2.90.

During the day across North America, the TSX Composite closed -0.54% at 22726.76, the S&P 500 closed -1.39% at 5588.27, the Dow Jones Industrial Average closed 0.59% at 41198.08 and the Nasdaq Composite closed -2.77% at 17996.92.

Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).

Trading volume was 75,198 on 247 total trades, while having an average volume of 92,746 over the last 5-days.

Trading across the entire TSX saw 1,017 price advancers against 4,222 declines and 91 unchanged.

During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, the shares have risen 153.27% in the last 52 weeks, while they have risen 146.36% since the start of 2024.

Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $201.24 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.

Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.

Cardiol Therapeutics Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..